SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-002493
Filing Date
2023-01-05
Accepted
2023-01-05 16:58:38
Documents
12
Period of Report
2023-01-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d428772d8k.htm   iXBRL 8-K 32794
  Complete submission text file 0001193125-23-002493.txt   151358

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aveo-20230105.xsd EX-101.SCH 2852
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20230105_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20230105_pre.xml EX-101.PRE 10813
6 EXTRACTED XBRL INSTANCE DOCUMENT d428772d8k_htm.xml XML 3265
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 23512248
SIC: 2834 Pharmaceutical Preparations